- When to consider referring for low-vision rehabilitation
- The role of sex hormones and aging in dry eye disease
- 3 reasons to read AOA’s newest clinical practice guideline
- Identifying reading difficulties in children
- Mobilizing against myopia
- New AOA clinical guideline puts focus on elevating care of glaucoma patients
- Tips for reinforcing optometry’s role in the broader health care system
- Vision loss makes list of 14 risk factors for dementia
- The ‘gatekeepers of primary eye care’
- Myopia report calls for disease classification, new federal policies
- High-tech solutions for low vision
- Optometrists play an integral role in assessing and treating patients with traumatic brain injuries.
- Primary care of the stroke patient
- Research on eye aberrations not abstract to award-winning scientists
- AOA, CooperVision mobilize to ‘disrupt the status quo,’ advance new standard of care for children with myopia
- What do the experts say on genetic testing for IRDs?
- Pediatric keratoconus prevalence higher than believed, may change care approach
- Making blurry vision clear
- Unblurring the lines
- Appreciating optometry’s value to patients with diabetes and their primary care physicians
- 9 benefits of introducing laser procedures into your practice
- 5 considerations if you’re thinking about adding laser procedures to your practice
- Optometrist-performed YAG capsulotomies shown effective, safe and beneficial for patients
- Proof not positive yet on low-dose atropine for myopia in children
- For 128 million U.S. presbyopes, doctors of optometry can provide treatment options
- What’s up, doc? Can a dietary supplement reverse patient cataracts?
- Legal blindness in America
- AOA webinar addresses concerns about myopia management
- AOA serving patients through research in optometry
- Marijuana sensibilities changing fast: Are you ready for patients’ questions?
- Buzz builds for AOA virtual ePosters event
- New technology for the advanced AMD patient
- Interprofessional communication for diabetic eye care
- Contact lens experts weigh in on gaps in consumer knowledge
- Align your team on binocular vision disorders
- How to better manage dry eye disease
- eyes the brain and learning
- Can vision intervention slow onset of dementia
- New independent task force recommendation on glaucoma screening underwhelms
- Gene therapy vision rehabilitation for IRDs
- 2022 contact lens controversies
- The latest research from AOA members
- Caring for patients with special needs
- New discoveries aid understanding of the visual system
- Don’t let the pressure get to you or your patients
- How technology has changed recommendations for visually impaired children
- 12 ways to provide better care for patients with prediabetes and diabetes
- Alzheimers and eyes
- Level up your diabetes care with specialists, services collaboration
- Behind the lens
- Contact lens developments regarding keratoconus
- Managing the care of patients with contact lens-related dry eye
- Lens-based strategies to address reading issues due to mild, disease-related vision loss
- Study shines light on optogenetics in retinitis pigmentosa
- surgical procedures courses
- Genetic Testing and Gene Therapy
- low vision in your practice
- Low percentage of patients with diabetes adhere to key self-care practices
- EBO to produce new glaucoma clinical practice guideline
- details of visual functions immediately following marijuana use
- Understanding Photophobia in mTBI
- New myopia management guidance released
- The challenges of maintaining a healthy tear film
- Integrating models of diabetic eye care
- Dry Eye and Productivity
- Contact lens innovation delivers opportunity
- How face masks affect the eyes
- Marijuana dispensaries still blow smoke over glaucoma effects
- Conjunctival Lymphangiectasia and Fabry
- Techniques to enhance contrast
- Americans remain at high risk for vision loss
- Stimulating eye and vision research
- Allergic conjunctivitis in a COVID-19 world
- Atropine in myopia control
- sleep patients ocular health
- CDC US coronavirus spread expected
- Demystifying dizziness
- Optometry and Glaucoma patients
- 5 reasons why doctors should use AOA diabetes guideline
- Growing epidemic of adolescents and young adults with prediabetes
- Improving scanning efficiency of individuals with homonymous hemianopia
- second edition of diabetes clinical practice guideline
- Pupil patterns in youth a phenomenon
- Study high school sports concussions underscores optometry role in care
- Prototype imager of tear film sublayers opens eyes on dry eye
- Retinal measurements hold clues to Alzheimers disease
- reversing prediabetes to normoglycemia can lessen microvascular complication risk
- Detecting the signs of autism at earlier age using visual cues
- Eye disorder CRISPR technology
- Addressing elderly vision impairment
- The AMD aspirin balancing act
- Study looks at what patients understand about their glaucoma diagnoses
- Vision Rehabilitation Clinical Pearls Lens Rx Prescribing for the Patient with Traumatic Brain Injury
- Real partners in diabetes care
- Amblyopia More than meets the eye
- New mild TBI guideline for children provides opportunity for doctors of optometry
- Reading corneal signs
- Eyes on Alzheimers disease
- Study looks at potential of suppressing ocular cancer in children
- Doctors of optometry are members of post-concussion team
- Glaucoma & Exercise
- The ABCs of MGD
- When T-cells go bad
- Study opens eyes to Alzheimers disease risk
- Understanding MGD
- Sjogren’s dry eye disease and depression
- Are patches the answer to amblyopia
- Oranges may allay AMD risk Pulp fact or fiction
- myopiatech
- Cognitive Decline
- Myopia Genes Discovered
- Link between diabetes and MGD
- alzheimers clues could be found using eye scan
- Genetic markers may help predict elevated IOP
- Ebola vector-borne diseases rear ugly heads again
- Blue lights link to prostate and breast cancers
- Can dyed contact lenses help color perception in CVD patients
- Omega 3 and Dry Eyes
- Glaucoma-Cannabinoid NP Drop
- Genetic Testing for AMD
- Premature Babies Low Birthweight Eyes
- ASD & Accommodative Function
- Stem Cells and Wet AMD
- Sjogren Awareness
- Brain Injury Awareness
- Sleep apneas interplay with corneal hysteresis
- New blood pressure guideline
- Low vision patient future
- Retinoblastoma-detecting ocular cancer in children
- Winter Dry Eye
- Low Vision and Blindness to Double
- New guidelines detecting retinoblastoma in children
- Glaucoma protein biomarker
- Risk for normal-tension glaucoma rises
- Peripheral reaction time faster in deaf adults
- New therapeutic target could reduce diabetic retinopathy
- diabetes on the rise among the young
- Trabeculoplasty Commentary
- Seniors near vision loss dementia risk linked
- Can frequent anti VEGF injections increase glaucoma surgery risk
- Study stresses stress test in treating patients with AMD
- Contact lens helps predict speed of glaucoma progression
- Unique retinal cell dysfunction triggers myopia
- Preeclampsia years later still takes toll
- How tilted optic discs may affect myopic eyes
- New eye test is early detector of diabetes
- Anti VEGF injections may not work for allglaucoma sooner
- New technique could diagnose glaucoma sooner
- Myopia incidence piques control efforts initiatives
- Study links visual impairment to physical and cognitive function declines
- Benefits unfamiliarity proves barrier to diabetes care
- Eyes on Alzheimers
- Association found between TBI and neurodegenerative conditions
- Spotting the link between vision problems and ADHD
- Treating the digital eye
- Statins show continued potential as treatment for dry AMD
- How doctors of optometry can diagnose a rare disorder
- Could eye drops be an alternative treatment to cataract surgery
- Researchers zero in on potential dry AMD treatment
- Ranibizumab proves effective to treat proliferative diabetic retinopathy
- Study shows some drivers with glaucoma naturally adapt
- Doctors of optometry a crucial component in cataract care
- Be part of the national dialogue about diabetes
- Under pressure addressing hypertension
- Gene therapy successful in treating rare retinal disorder
- The lowdown on treating low vision patients
- New study calls attention to importance of carotenoids
- 5 things doctors of optometry should know about concussions
- Can a supplement fight diabetic retinopathy
- Outdoor activity may reduce risk for myopia in children
- 3 reasons comprehensive exams matter for diabetes
- Diabetes and Prediabetes
- Vitamin C may slow progress of cataracts
- Multifocal contact lens effective at treating myopia in kids
- New tool educates and motivates patients with diabetes related eye disease
- Myopia Its in your genes too
- Out of the box thinking leads to potential glaucoma treatment
- Doctors of optometry have big role in catching giant cell arteritis before blindness
- Cataract surgery lessens death risk
- Novel glaucoma therapy One ring to help them all
- Common glaucoma drugs may affect IOP measurements
- Gene mutation uncovers potential treatment for rare form of pediatric glaucoma
- How astigmatism affects reading fluency
- FDA approves first corneal cross linking system for treatment
- Cataracts and UV exposure in driver-side windows
- Virtual model aids diabetic retinopathy progression understanding
- doctors of optometry AMD assessments comparable to ophthalmologistsoutcomes
- Parkinsons detectable through eye exam
- Are sleep apnea and asthma linked to keratoconus
- Not a dry eye
- Eye on head injuries
- Risk for macular degeneration linked to low levels of vitamin D
- Tears now fears Zika persists in eyes
- Myopia Controlling the heretofore uncontrollable
- advancing keratoconus care
- visual dysfunction after brain injury
- Study detects early biomarkers for risk of developing diabetic retinopathy
- Prevalence of Undiagnosed AMD
- Daily use of steroid drops increases risk for ocular hypertension
- Zikababy
- New study dry eye disease
- Encyclopedia of dry eye disease released
- Clinical Pearls for Seasonal Allergies
- Doctors of optometry less likely to prescribe seldom needed antibiotics for conjunctivitis
- T cells hold promise of treatment for preemies born with eye condition
- Youth Concussions
- New imaging techniques detect earlystage Alzheimer’s disease
New AOA adult eye guideline offers 14 actions, provides fresh insight on exam frequency
March 9, 2023
After a systematic review of the evidence and assessment of the benefits and harms of treatment options, the AOA’s Evidence-based Optometry Committee offers new consensus on the frequency of eye exams for adults ages 18-39 and details the potential components of a comprehensive adult eye examination.
Sobering statistics, 14 evidence- and consensus-based action steps, a partial list of systemic diseases with ocular complications, and a slight but significant shift in a recommendation on frequency of care—all are in the clarifying and pacesetting second edition of the AOA evidence-based clinical practice guideline, Comprehensive Adult Eye and Vision Examination, Second Edition, just released.
Originally published in 2015, the updated adult eye and vision examination guideline was developed over 16 months and “describes appropriate examination procedures for evaluation of the eye health and vision status of adult patients to reduce the risk of vision loss and provide clear, comfortable vision. It contains recommendations for timely diagnosis, intervention, and, when necessary, referral for consultation with and/or treatment by another health care provider.”
The guideline’s objectives include enabling doctors of optometry to:
- Recommend appropriate timetables for eye and vision examinations for adults.
- Select appropriate examination procedures for adults.
- Examine eye health, vision status and ocular manifestations of systemic disease in adults.
- Minimize/avoid the effects of eye and vision problems in adults through prevention, early detection and diagnosis, and patient management through education and counseling.
- Inform/educate individuals and other health care practitioners on the importance of good vision and the need for, and frequency of, comprehensive adult eye and vision exams.
“The goal of the Evidence-based Optometry (EBO) Committee is to develop a guideline that all of optometry can follow, to adjust their practice based on what the best evidence shows,” says Carl Urbanski, O.D., chair of the EBO Committee, who was also on hand for the release of the first adult eye guideline.
“Doctors of optometry are lifelong learners, and the committee took the most current evidence and delivered it in a format that works for our clinicians, so they can adjust their mode of practice to fit what the evidence shows is the best way to approach diagnosis and care of the patient. It also serves as a resource to other health care professions, as well as the public.”
Says AOA President Ronald L. Benner: “This update solidifies the work and commitments of the AOA to create an evidence-based guideline tool for our doctors to provide the care our patients deserve. The amount of volunteer time that was spent to produce and get this guideline right shows the commitment that the AOA has made to advance the patient care provided by optometry across the country.”
In an interview, Dr. Urbanski reveals more about the revised guideline.
What is new and significant?
The guideline is a valuable resource and a great refresher for all doctors of optometry. I’d recommend going to the background section and re-reading the section on the prevalence of eye disease and the predictions for say 2050 on how much is going to be developing. It really contains compelling data that there is a huge need for eye care. We know about the workforce of optometry vs. ophthalmology. Optometry is really going to need to fill the gap and supply the care that is needed. There is an enormous amount of need out there. Optometry is really going to have to step into that role, especially given our expanded scope.
Table 1 in the document is very relevant. It speaks to systemic disease that has ocular complications. In the patient education section, there are some papers that talk about effective ways to communicate with our patients and helping with adherence to treatment. Perhaps the single biggest change is the frequency of care.
How does the frequency of care depart from the first guideline’s consensus statement on eye exams for adults every two years?
We did not find specific evidence that said every adult should have an annual eye exam. There remains a gap in the evidence. But we did put together a strong consensus statement. We recommended comprehensive eye and vision examinations annually for people 18 to 39 years of age to optimize visual function, evaluate eye changes and provide for the earlier detection of sight-threatening eye and systemic health conditions. The clinician really needs to evaluate the risk factors present. Based on this consensus and the expert opinion of the committee, implementation of this recommendation will likely result in earlier diagnosis of eye and vision problems and prevention of vision loss. We are recommending annually for everyone as a more proactive approach. This new statement will give the clinician confidence to recommend an annual eye exam to their adult patients.
Producing a trustworthy guideline is a rigorous, systematic, 14-step process. Can you describe the process?
If you want to keep your guideline trustworthy and relevant, you have to go back and assess the evidence periodically and make sure it’s current. Anything that rose to the level of a clinical recommendation, we go back and re-research those areas and re-read those papers and grade them and see if anything else has been published. (The new guideline has 229 citations.) Obviously, we also look for any new evidence-based on the questions we are trying to answer for the new guideline. We also try to identify gaps in evidence. For example, if we couldn’t find good information on a topic before, we will go back and make sure we research where the prior gaps were and try and fill those in. As a committee, we try to evaluate and ask what the profession needs. We want to deliver content that’s useful to our clinicians, accessible through the AOA website and something they can put into action in clinical practice.
How does the committee want doctors and other health professions to use the guideline?
We hope doctors of optometry and their staff look at the evidence-based and consensus-based recommendations, for starters, because the guideline has very strong evidence, multiple citations for our clinical recommendations. Doctors may look up a certain treatment protocol. Maybe there’s a table they’re going to download and print. That’s what we would hope they would do. Take that information and make it part of their day-to-day practice, but then also go back to it when they need it and use it as a reference. They might, for instance, consult the guideline to see what instrument or exam technique is best to evaluate an ocular issue. We also hope that when doctors of optometry attend continuing education that our lecturers are using our guidelines as resources with the evidence-based recommendations as part of their delivery of content. We also hope the same applies to optometry schools, where they can look to these guidelines when they are developing curriculum for future clinicians.
Explain more about the hard-working EBO Committee.
That seems to be the reputation we have in the AOA. The committee is a mix of doctors from lots of different modes of practice. Myself and some of the other doctors are in private practice. We have a fair number of academic faculty who also have clinical roles with their respective institutions. And we have several doctors who work in multidisciplinary settings. We have content experts as well, on teams that specialize in the guideline topic we are writing. Overall, what we look for is someone who obviously is active in clinical practice and then we follow our 14-step process. Over the past two years or so, we have been running two different guidelines. One is the primary open angle glaucoma guideline, which we are still working on, and then there is this, the second edition of the adult eye guideline. We also may have a practicing physician or an ophthalmologist on the guideline team, depending on the topic. We have a patient and a patient advocate as well. We are careful to stick to our process and everyone is vetted as far as bias on the topic.
See all of the EBO Committee’s previously published clinical practice guidelines, myopia clinical report and consensus-based guidelines.